Literature DB >> 24047971

Antiretroviral treatment interruptions induced by the Kenyan postelection crisis are associated with virological failure.

Marita Mann1, Lameck Diero2,3, Emmanuel Kemboi2,3, Fidelis Mambo2,3, Mary Rono2,3, Wilfred Injera2,3, Allison Delong4, Leeann Schreier5, Kara W Kaloustian6, John Sidle7, Nathan Buziba2,3, Rami Kantor5.   

Abstract

BACKGROUND: Antiretroviral treatment interruptions (TIs) cause suboptimal clinical outcomes. Data on TIs during social disruption are limited.
METHODS: We determined effects of unplanned TIs after the 2007-2008 Kenyan postelection violence on virological failure, comparing viral load (VL) outcomes in HIV-infected adults with and without conflict-induced TI.
RESULTS: Two hundred and one patients were enrolled, median 2.2 years after conflict and 4.3 years on treatment. Eighty-eight patients experienced conflict-related TIs and 113 received continuous treatment. After adjusting for preconflict CD4, patients with TIs were more likely to have detectable VL, VL >5,000 and VL >10,000.
CONCLUSIONS: Unplanned conflict-related TIs are associated with increased likelihood of virological failure.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24047971      PMCID: PMC3920989          DOI: 10.1097/QAI.0b013e31829ec485

Source DB:  PubMed          Journal:  J Acquir Immune Defic Syndr        ISSN: 1525-4135            Impact factor:   3.731


  27 in total

Review 1.  Adherence-resistance relationships to combination HIV antiretroviral therapy.

Authors:  David R Bangsberg; Deanna L Kroetz; Steven G Deeks
Journal:  Curr HIV/AIDS Rep       Date:  2007-05       Impact factor: 5.071

2.  Development of HIV with drug resistance after CD4 cell count-guided structured treatment interruptions in patients treated with highly active antiretroviral therapy after dual-nucleoside analogue treatment.

Authors:  Reto Nuesch; Jintanat Ananworanich; Sunee Sirivichayakul; Sasiwimol Ubolyam; Umaporn Siangphoe; Andrew Hill; David Cooper; Joep Lange; Praphan Phanuphak; Kiat Ruxrungtham
Journal:  Clin Infect Dis       Date:  2005-02-04       Impact factor: 9.079

3.  Misclassification of first-line antiretroviral treatment failure based on immunological monitoring of HIV infection in resource-limited settings.

Authors:  Rami Kantor; Lameck Diero; Allison Delong; Lydia Kamle; Sarah Muyonga; Fidelis Mambo; Eunice Walumbe; Wilfred Emonyi; Philip Chan; E Jane Carter; Joseph Hogan; Nathan Buziba
Journal:  Clin Infect Dis       Date:  2009-08-01       Impact factor: 9.079

4.  Sequence quality analysis tool for HIV type 1 protease and reverse transcriptase.

Authors:  Allison K Delong; Mingham Wu; Diane Bennett; Neil Parkin; Zhijin Wu; Joseph W Hogan; Rami Kantor
Journal:  AIDS Res Hum Retroviruses       Date:  2011-10-26       Impact factor: 2.205

5.  Non-adherence to antiretroviral treatment and unplanned treatment interruption among people living with HIV/AIDS in Cameroon: Individual and healthcare supply-related factors.

Authors:  Sylvie Boyer; Isabelle Clerc; Cécile-Renée Bonono; Fabienne Marcellin; Paule-Christiane Bilé; Bruno Ventelou
Journal:  Soc Sci Med       Date:  2011-03-08       Impact factor: 4.634

Review 6.  Effects of political conflict-induced treatment interruptions on HIV drug resistance.

Authors:  Marita Mann; Mark N Lurie; Sylvester Kimaiyo; Rami Kantor
Journal:  AIDS Rev       Date:  2013 Jan-Mar       Impact factor: 2.500

7.  Virological failure and drug resistance in patients on antiretroviral therapy after treatment interruption in Lilongwe, Malawi.

Authors:  Julia Luebbert; Hannock Tweya; Sam Phiri; Thom Chaweza; Johnbosco Mwafilaso; Mina C Hosseinipour; Heribert Ramroth; Paul Schnitzler; Florian Neuhann
Journal:  Clin Infect Dis       Date:  2012-05-09       Impact factor: 9.079

8.  Treatment interruption and variation in tablet taking behaviour result in viral failure: a case-control study from Cape Town, South Africa.

Authors:  Lisa-Noelle Ncaca; Katharina Kranzer; Catherine Orrell
Journal:  PLoS One       Date:  2011-08-08       Impact factor: 3.240

9.  Impact of the Kenya post-election crisis on clinic attendance and medication adherence for HIV-infected children in western Kenya.

Authors:  Rachel C Vreeman; Winstone M Nyandiko; Edwin Sang; Beverly S Musick; Paula Braitstein; Sarah E Wiehe
Journal:  Confl Health       Date:  2009-04-04       Impact factor: 2.723

10.  Not all missed doses are the same: sustained NNRTI treatment interruptions predict HIV rebound at low-to-moderate adherence levels.

Authors:  Jean-Jacques Parienti; Moupali Das-Douglas; Véronique Massari; David Guzman; Steven G Deeks; Renaud Verdon; David R Bangsberg
Journal:  PLoS One       Date:  2008-07-30       Impact factor: 3.240

View more
  14 in total

1.  Impact of Unplanned Care Interruption on CD4 Response Early After ART Initiation in a Nigerian Cohort.

Authors:  Aimalohi A Ahonkhai; Juliet Adeola; Bolanle Banigbe; Ifeyinwa Onwuatuelo; Abdulkabir B Adegoke; Ingrid V Bassett; Elena Losina; Kenneth A Freedberg; Prosper Okonkwo; Susan Regan
Journal:  J Int Assoc Provid AIDS Care       Date:  2016-10-10

2.  HIV-1 second-line failure and drug resistance at high-level and low-level viremia in Western Kenya.

Authors:  Rami Kantor; Allison DeLong; Leeann Schreier; Marissa Reitsma; Emanuel Kemboi; Millicent Orido; Salome Obonge; Robert Boinett; Mary Rono; Wilfred Emonyi; Katie Brooks; Mia Coetzer; Nathan Buziba; Joseph Hogan; Lameck Diero
Journal:  AIDS       Date:  2018-11-13       Impact factor: 4.177

3.  Improved HIV-1 Viral Load Monitoring Capacity Using Pooled Testing With Marker-Assisted Deconvolution.

Authors:  Tao Liu; Joseph W Hogan; Michael J Daniels; Mia Coetzer; Yizhen Xu; Gerald Bove; Allison K DeLong; Lauren Ledingham; Millicent Orido; Lameck Diero; Rami Kantor
Journal:  J Acquir Immune Defic Syndr       Date:  2017-08-15       Impact factor: 3.731

4.  Impact and Cost-Effectiveness of Hypothetical Strategies to Enhance Retention in Care within HIV Treatment Programs in East Africa.

Authors:  Jason Kessler; Kimberly Nucifora; Lingfeng Li; Lauren Uhler; Scott Braithwaite
Journal:  Value Health       Date:  2015-11-17       Impact factor: 5.725

5.  The Perspective of HIV Providers in Western Kenya on Provider-Patient Relationships.

Authors:  Juddy Wachira; Becky Genberg; Catherine Kafu; Beatrice Koech; Jacqueline Akinyi; Regina K Owino; Michael Barton Laws; Ira B Wilson; Paula Braitstein
Journal:  J Health Commun       Date:  2018-07-06

6.  Stigma Determines Antiretroviral Adherence in Adults With HIV in Myanmar.

Authors:  Su Aung; Nicole Hardy; Stavroula A Chrysanthopoulou; Aung Kyaw; Min San Tun; Khaymar Win Aung; Aadia Rana; Rami Kantor
Journal:  J Acquir Immune Defic Syndr       Date:  2022-01-01       Impact factor: 3.771

7.  Classification using ensemble learning under weighted misclassification loss.

Authors:  Yizhen Xu; Tao Liu; Michael J Daniels; Rami Kantor; Ann Mwangi; Joseph W Hogan
Journal:  Stat Med       Date:  2019-01-04       Impact factor: 2.373

8.  HIV-1 Treatment Failure, Drug Resistance, and Clinical Outcomes in Perinatally Infected Children and Adolescents Failing First-Line Antiretroviral Therapy in Western Kenya.

Authors:  Winstone Nyandiko; Sabina Holland; Rachel Vreeman; Allison K DeLong; Akarsh Manne; Vladimir Novitsky; Festus Sang; Celestine Ashimosi; Anthony Ngeresa; Ashley Chory; Josephine Aluoch; Millicent Orido; Eslyne Jepkemboi; Soya S Sam; Angela M Caliendo; Samuel Ayaya; Joseph W Hogan; Rami Kantor
Journal:  J Acquir Immune Defic Syndr       Date:  2022-02-01       Impact factor: 3.771

9.  HIV diversity and drug resistance from plasma and non-plasma analytes in a large treatment programme in western Kenya.

Authors:  Rami Kantor; Allison DeLong; Maya Balamane; Leeann Schreier; Robert M Lloyd; Wilfred Injera; Lydia Kamle; Fidelis Mambo; Sarah Muyonga; David Katzenstein; Joseph Hogan; Nathan Buziba; Lameck Diero
Journal:  J Int AIDS Soc       Date:  2014-11-18       Impact factor: 5.396

Review 10.  Contemporary issues on the epidemiology and antiretroviral adherence of HIV-infected adolescents in sub-Saharan Africa: a narrative review.

Authors:  Olurotimi A Adejumo; Kathleen M Malee; Patrick Ryscavage; Scott J Hunter; Babafemi O Taiwo
Journal:  J Int AIDS Soc       Date:  2015-09-16       Impact factor: 5.396

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.